Tower Research Capital LLC TRC Boosts Stock Position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
MarketBeat
Tower Research Capital LLC TRC raised its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 1,946.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,369 shares of the company's stock after buying an addition
NASDAQ:PTGX